US Approves Imatinib for Children With Ph+ Acute Lymphoblastic Leukemia

Imatinib has been approved to treat children newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia, the U.S. Food and Drug Administration announced Jan. 25.Imatinib, a tyrosine...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news